Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q07617
UPID:
SPAG1_HUMAN
Alternative names:
HSD-3.8; Infertility-related sperm protein Spag-1
Alternative UPACC:
Q07617; A6NP70; B3KQ58; G3XAM3; Q7Z5G1
Background:
Sperm-associated antigen 1, also known as HSD-3.8 or Infertility-related sperm protein Spag-1, plays a crucial role in the cytoplasmic assembly of ciliary dynein arms, suggesting its involvement in motility and fertilization processes. This protein's ability to bind GTP and exhibit GTPase activity further underscores its biological significance.
Therapeutic significance:
Given its association with Primary Ciliary Dyskinesia, particularly type 28, which leads to chronic respiratory infections and potentially Kartagener syndrome, understanding the role of Sperm-associated antigen 1 could unveil novel therapeutic strategies aimed at mitigating these ciliary motility disorders.